U.S. federal trademark · Serial No. 98589564 · Reg. No. TMA 1
Radiopharmaceutical drug delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical theranostic delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical imaging delivery agent in the form of an intracellular and nuclear enhancer; medicinal preparations for use in oncology; pharmaceutical radio-immuno-conjugate (radiolabeled antibody) preparations for the treatment, diagnosis and theranosis of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical radiolabeled antibodies for the treatment, diagnosis and theranosis of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; radio-immuno-conjugates for treating cancer; vaccines for human use
Antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of immunotherapy; scientific research for medical purposes in the field of oncology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.